Narcotic Analgesics Flashcards

1
Q

What are the 3 opioid receptors and their distribution?

A

μ = primary and peripheral sensory neurons, periaqueductal grey matter, nucleus raphe magnus, rostral ventral medulla, thalamus, cortex

κ = hypothalamus, nociception areas

δ = olfactory bulb, cerebral cortex, presynaptic on primary afferent neurons, motor integration areas, and nociception areas

[Note that all 3 major receptors are present in high concentrations in the dorsal horn of the SC. Receptors are present both on SC pain transmission neurons and on the primary afferents that relay the pain message to them. Although opioid agonists directly inhibit dorsal horn pain transmission neurons, they also inhibit the release of excitatory transmitters from the primary afferents. Importantly, the μ receptor is associated with TRPV1 and substance-P-expressing nociceptors, whereas δ-receptor expression predominates in the nonpeptidergic population of nociceptors, including many primary afferents with myelinated axons]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Opioids classified as strong agonists

A
Fentanyl (+sufentanil, alfentanil,remifentanil)
Hydromorphone
Meperidine
Morphine
Methadone
Oxymorphone
Levorphenol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Fentanyl, hydromorphine, meperidine, morphine, methadone, and oxymorphone are considered strong opioid agonists. What is their MOA (receptors) and clinical application?

A

MOA: strong μ receptor agonists; variable κ and δ agonists

Clinical: severe pain, anesthesia adjuncts, dependence maintenance (methadone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which opioids are considered partial agonists (bind same receptors as strong agonists but with lower affinity)?

What are their clinical applications?

A

Codeine
Hydrocodone

Clinically: mild-to-moderate pain; cough (codeine), analgesic combinations with NSAIDs or acetaminophen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which opioids are classified as mixed agonist-antagonists?

A

Buprenorphine
Nalbuphine
Pentazocine
Butorphanol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MOA and clinical application of Buprenorphine

A

Partial μ agonist and κ antagonist

Moderate to severe pain; dependence maintenance — reduces craving for alcohol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Of the mixed agonist-antagonists, ______ has a long duration of action, while _______ is parenteral only

A

Buprenorphine; nalbuphine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

MOA and clinical application of Nalbuphine

A

κ agonist and μ antagonist

Clinically: moderate-to-severe pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some opioid antagonists and what is their primary clinical application?

A

Naloxone
Naltrexone
Nalmefene

Used to reverse opioid overdose [naltrexone can be used for dependence maintenance]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Of the opioid antagonists, ______ has a duration of about 2 hours, while _____ and ____ last >10 hrs

A

Naloxone; naltrexone and nalmefene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which opioid is utilized as an antitussive? What is its MOA?

A

Codeine, dextromethorphan

Full mechanism uncertain; weak μ agonist, inhibits NE and 5-HT transporters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

______ is a weak μ agonist and blocks serotonin reuptake. It is used in cases of moderate pain, often as an adjunctive to opioids in chronic pain states. It causes seizures at toxic levels

A

Tramadol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What effects might the following physiological states have on opioid metabolism: obesity, elderly, infant, renal failure, or hepatic failure

A

Obesity: increased risk of overdose (central Vd not reflected by actual body weight)

Elderly: increased sensitivity to opioid, prolonged effect of infusion

Infant: prolonged effect

Renal failure: morphine or pethidine toxicity

Hepatic failure: increased sensitivity to opioids (in severe liver failure only)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

General MOA of μ receptor agonists (presynaptic and postsynaptic)

A

All are linked to G-protein (GPCRs)

Presynaptic μ-receptor activation inhibits calcium influx into sensory neurons, which decreases NT release

Postsynaptic μ-receptor activation increases K+ efflux, which decreases postsynaptic response to excitatory neurotransmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which opioid is used for pulmonary edema?

A

Morphine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

T/F: hydromorphine and oxymorphone are like morphine in efficacy but lower potency

A

False; hydromorphine and oxymorphone are like morphine in efficacy but HIGHER potency

17
Q

Which of the opioid agonists is considered a strong agonist with anticholinergic effects?

A

Meperidine

18
Q

T/F: sufentanil, alfentanil, remifentanil are like fentanyl but with shorter durations of action

A

True

19
Q

Opioid antagonist used in maintenance programs and can block heroin effects for up to 48 hrs; also used for alcohol and nicotine dependence and, when combined with buproprion, may be effective in weight-loss programs

A

Naltrexone

20
Q

Potent μ-receptor antagonists with poor entry into the CNS; can be used to treat severe opioid-induced constipation without precipitating an abstinence syndrome

A

Alvimopan

Methylnaltrexone bromide

21
Q

Moderate μ-receptor agonist and strong NET inhibitor used to promote analgesia in cases of moderate pain; at toxic levels may cause headache, nausea, vomiting, and possible dependence

A

Tapentadol

22
Q

Endogenous opioid peptide affinity of each of the opioid receptor subtypes

A

μ = endorphins > enkephalins > dynorphins

δ = enkephalins > endorphins and dynorphins

κ = dynorphins&raquo_space; endorphins and enkephalins

23
Q

Adverse effects with acute use of opioid analgesics

A
Respiratory depression
Nausea/vomiting
Pruritis
Urticaria
Constipation
Urinary retention
Delirium
Sedation
Myoclonus
Seizures
Truncal rigidity
Hyper or hypothermia
24
Q

Adverse effects with chronic use of opioid analgesics

A
Hypogonadism
Immunosuppression
Increased feeding
Increased growth hormone secretion
Withdrawal effects
Tolerance, dependence
Abuse, addiction
Hyperalgesia
Impairment while driving
25
Q

Contraindications to opioid analgesic use (e.g., morphine)

A

Acute respiratory depression

Renal failure (d/t accumulation of metabolites morphine-3-glucuronide and morphine-6-glucuronide)

Chemical toxicity (potentially lethal in low-tolerance individuals)

Raised intracranial pressure, including head injury (risk of worsening respiratory depression)

Biliary colic

Pregnancy

Endocrine disease

26
Q

Why are oral doses of narcotics typically higher than parenteral doses?

A

First-pass effect

However, certain analgesics like codeine and oxycodone are effective orally because they have reduced first-pass metabolism; can also get around this by fiving nasally, oral mucosa (lozenges), or transdermal

27
Q

General metabolism of opioids

A

Many opioids undergo hepatic P450 degradation then are converted in large part to polar metabolites (mostly glucuronides), which are then readily excreted by the kidneys.

Examples: Fentanyl (CYP3A4), Codeine/oxycodone/hydrocodone (CYP2D6), methadone (CYP2B6)

Note that esters such as heroin and remefentanil undergo plasma esterase metabolism

28
Q

Effect of opioids on the uterus

A

Prolonged labor

29
Q

Effect of opioids on endocrine system

A

Stimulate release of ADH, prolactin, and somatotropin

Inhibit release of LH

With chronic therapy: low testosterone (men), dysmenorrhea or amenorrhea (women)